Company registration number 04575260 (England and Wales)
OKB MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
OKB MEDICAL LIMITED
CONTENTS
Page
Balance sheet
2
Notes to the financial statements
3 - 6
OKB MEDICAL LIMITED
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF OKB MEDICAL LIMITED FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of OKB Medical Limited for the year ended 31 December 2025 set out on pages 2 to 6 from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the b oard of d irectors of OKB Medical Limited, as a body, in accordance with the terms of our engagement letter dated 22 July 2025. Our work has been undertaken solely to prepare for your approval the financial statements of OKB Medical Limited and state those matters that we have agreed to state to the b oard of d irectors of OKB Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than OKB Medical Limited and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that OKB Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of OKB Medical Limited. You consider that OKB Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of OKB Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Carpenter Box
7 April 2026
Chartered Accountants
Piper House
4 Dukes Court
Bognor Road
Chichester
West Sussex
PO19 8FX
OKB MEDICAL LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
3
307,056
315,683
Investment property
4
1,159,000
1,163,000
Investments
5
608,826
-
0
2,074,882
1,478,683
Current assets
Debtors
6
730,622
669,984
Cash at bank and in hand
2,230,717
2,934,412
2,961,339
3,604,396
Creditors: amounts falling due within one year
7
(15,317)
(47,785)
Net current assets
2,946,022
3,556,611
Net assets
5,020,904
5,035,294
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
5,020,804
5,035,194
Total equity
5,020,904
5,035,294

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 28 March 2026 and are signed on its behalf by:
Mr R Norum
Director
Company registration number 04575260 (England and Wales)
OKB MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

OKB Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is Piper House, 4 Dukes Court, Bognor Road, West Sussex, Chichester, PO19 8FX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
Not depreciated
Plant and machinery
33% straight line
Fixtures, fittings & equipment
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value a t the reporting end date. Changes in fair value are recognised in profit or loss.

OKB MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in profit and loss. Transaction costs are expensed to profit and loss as incurred.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

OKB MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 3 (2024 - 2).

3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025 and 31 December 2025
298,255
61,320
359,575
Depreciation and impairment
At 1 January 2025
-
0
43,892
43,892
Depreciation charged in the year
-
0
8,627
8,627
At 31 December 2025
-
0
52,519
52,519
Carrying amount
At 31 December 2025
298,255
8,801
307,056
At 31 December 2024
298,255
17,428
315,683
4
Investment property
2025
£
Fair value
At 1 January 2025
1,163,000
Revaluations
(4,000)
At 31 December 2025
1,159,000

Investment property comprises of three residential properties. The fair value of the investment properties has been arrived at on the basis of a valuation carried out by the director, Mr R Norum. No professional valuation has been carried out by independent surveyors who are not connected with the company. The valuation was made on an open market value basis.

5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
608,826
-
0
OKB MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
5
Fixed asset investments
(Continued)
- 6 -
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 January 2025
-
Additions
602,800
Valuation changes
17,878
Disposals
(11,852)
At 31 December 2025
608,826
Carrying amount
At 31 December 2025
608,826
At 31 December 2024
-
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
7,500
Other debtors
730,622
662,484
730,622
669,984
7
Creditors: amounts falling due within one year
2025
2024
£
£
as restated
Trade creditors
1,161
1,316
Taxation and social security
4,692
23,360
Other creditors
9,464
23,109
15,317
47,785
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
2025-12-31 2025-01-01 false false false 07 April 2026 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr R Norum Mrs E Norum Mr R Norum 3 04575260 2025-01-01 2025-12-31 04575260 2025-12-31 04575260 2024-12-31 04575260 core:LandBuildings 2025-12-31 04575260 core:OtherPropertyPlantEquipment 2025-12-31 04575260 core:LandBuildings 2024-12-31 04575260 core:OtherPropertyPlantEquipment 2024-12-31 04575260 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 04575260 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 04575260 core:CurrentFinancialInstruments 2025-12-31 04575260 core:CurrentFinancialInstruments 2024-12-31 04575260 core:ShareCapital 2025-12-31 04575260 core:ShareCapital 2024-12-31 04575260 core:RetainedEarningsAccumulatedLosses 2025-12-31 04575260 core:RetainedEarningsAccumulatedLosses 2024-12-31 04575260 core:ShareCapitalOrdinaryShareClass1 2025-12-31 04575260 core:ShareCapitalOrdinaryShareClass1 2024-12-31 04575260 bus:CompanySecretaryDirector1 2025-01-01 2025-12-31 04575260 core:LandBuildings core:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 04575260 core:PlantMachinery 2025-01-01 2025-12-31 04575260 core:FurnitureFittings 2025-01-01 2025-12-31 04575260 core:LandBuildings 2024-12-31 04575260 core:OtherPropertyPlantEquipment 2024-12-31 04575260 2024-12-31 04575260 core:LandBuildings 2025-01-01 2025-12-31 04575260 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 04575260 core:WithinOneYear 2025-12-31 04575260 core:WithinOneYear 2024-12-31 04575260 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 04575260 bus:OrdinaryShareClass1 2025-12-31 04575260 bus:OrdinaryShareClass1 2024-12-31 04575260 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 04575260 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 04575260 bus:FRS102 2025-01-01 2025-12-31 04575260 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 04575260 bus:Director1 2025-01-01 2025-12-31 04575260 bus:Director2 2025-01-01 2025-12-31 04575260 bus:CompanySecretary1 2025-01-01 2025-12-31 04575260 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP